U.S. flag

An official website of the United States government

NM_001110792.2(MECP2):c.379C>T (p.Arg127Cys) AND Severe neonatal-onset encephalopathy with microcephaly

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 17, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002514765.4

Allele description [Variation Report for NM_001110792.2(MECP2):c.379C>T (p.Arg127Cys)]

NM_001110792.2(MECP2):c.379C>T (p.Arg127Cys)

Gene:
MECP2:methyl-CpG binding protein 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_001110792.2(MECP2):c.379C>T (p.Arg127Cys)
Other names:
p.R115C:CGC>TGC; NM_001110792.2(MECP2):c.379C>T; p.Arg127Cys
HGVS:
  • NC_000023.11:g.154032241G>A
  • NG_007107.3:g.109863C>T
  • NM_001110792.2:c.379C>TMANE SELECT
  • NM_001316337.2:c.64C>T
  • NM_001369391.2:c.64C>T
  • NM_001369392.2:c.64C>T
  • NM_001369393.2:c.64C>T
  • NM_001369394.2:c.64C>T
  • NM_001386137.1:c.-218C>T
  • NM_001386138.1:c.-218C>T
  • NM_001386139.1:c.-218C>T
  • NM_004992.4:c.343C>T
  • NP_001104262.1:p.Arg127Cys
  • NP_001303266.1:p.Arg22Cys
  • NP_001356320.1:p.Arg22Cys
  • NP_001356321.1:p.Arg22Cys
  • NP_001356322.1:p.Arg22Cys
  • NP_001356323.1:p.Arg22Cys
  • NP_004983.1:p.Arg115Cys
  • NP_004983.1:p.Arg115Cys
  • LRG_764t1:c.379C>T
  • LRG_764t2:c.343C>T
  • AJ132917.1:c.343C>T
  • LRG_764:g.109863C>T
  • LRG_764p1:p.Arg127Cys
  • LRG_764p2:p.Arg115Cys
  • NC_000023.10:g.153297692G>A
  • NC_000023.10:g.153297692G>A
  • NG_007107.2:g.109887C>T
  • NM_004992.3:c.343C>T
Protein change:
R115C
Links:
dbSNP: rs267608388
NCBI 1000 Genomes Browser:
rs267608388
Molecular consequence:
  • NM_001386137.1:c.-218C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001386138.1:c.-218C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001386139.1:c.-218C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001110792.2:c.379C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001316337.2:c.64C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369391.2:c.64C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369392.2:c.64C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369393.2:c.64C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369394.2:c.64C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004992.4:c.343C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Severe neonatal-onset encephalopathy with microcephaly
Synonyms:
Encephalopathy, neonatal severe; Encephalopathy, neonatal severe, due to MECP2 mutations
Identifiers:
MONDO: MONDO:0010397; MedGen: C1968556; Orphanet: 209370; OMIM: 300673

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003445290Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Apr 17, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Multiple de novo mutations in the MECP2 gene.

Bunyan DJ, Robinson DO.

Genet Test. 2008 Sep;12(3):373-5. doi: 10.1089/gte.2008.0012.

PubMed [citation]
PMID:
18652533

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003445290.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This missense change has been observed in individual(s) with clinical features of Rett syndrome (PMID: 18652533). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MECP2 protein function. ClinVar contains an entry for this variant (Variation ID: 143541). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 115 of the MECP2 protein (p.Arg115Cys).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024